Neuralstem (CUR) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free CUR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAguas Da Curia Share Price (CUR.LS)lse.co.uk - November 25 at 8:24 PMXAUUSD:CUR Gold Spot Priceseekingalpha.com - August 22 at 3:27 PM4 Biotech Stocks Under $10 Moving Higherthestreet.com - July 20 at 3:23 PMXPTUSD:CUR Platinum Spot Priceseekingalpha.com - June 28 at 1:20 PMXAUUSD:CURseekingalpha.com - May 16 at 11:17 AMNovAccess Global : Announces Fireside Chat with Board Member Perspectives - Marketscreener.commarketscreener.com - October 20 at 9:12 AMAnti-inflammatory compound supercharges stem cell stroke treatment - Yahoo Newsnews.yahoo.com - October 12 at 3:55 PMBest microscope photos of 2022 reveal stunning hidden world around us - Business Insiderbusinessinsider.com - October 11 at 2:30 PMStem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzingabenzinga.com - October 11 at 9:29 AMAruna Bio Announces Presentation on Neural Exosome Treatment Opportunities and Lead Program, AB126 at Exosome Based Therapeutic Development Summit - GlobeNewswireglobenewswire.com - October 6 at 8:32 AMBOLDEN THERAPEUTICS RECEIVES $406,466 SBIR GRANT FROM THE NATIONAL INSTITUTE ON AGING TO SUPPORT DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDES TO PROMOTE NEUROGENESIS - StreetInsider.comstreetinsider.com - September 16 at 1:40 PMBGI-led Research Builds the World's First Spatiotemporal Map of Brain Regeneration - PR Newswireprnewswire.com - September 2 at 5:00 AMGlobal Recurrent Glioblastoma Pipeline Insight | Clinical Trials Research Report 2022 by DelveInsight - GlobeNewswireglobenewswire.com - August 23 at 6:14 PMHow Scientists Successfully Reversed Alzheimer's in Mice - Newsweeknewsweek.com - August 23 at 4:44 AMDioseve wants to help infertile people with tech that grows egg cells - TechCrunchtechcrunch.com - August 22 at 11:44 PMThe Global Stem Cell Manufacturing Market grew USD 4,378.00 million by 2027, at a CAGR of 12.23%. - Yahoo Financefinance.yahoo.com - August 12 at 7:25 PMThe Global Stem Cell Manufacturing Market grew USD 4,378.00 - GlobeNewswireglobenewswire.com - August 12 at 9:59 AMCalidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma - Yahoo Financefinance.yahoo.com - August 4 at 2:53 AMCalidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma - Business Wirebusinesswire.com - August 2 at 8:45 AMHow chickenpox virus is linked to onset of Alzheimer's disease - Investing.com Indiain.investing.com - August 1 at 2:13 AMCan Inflammation Lead To Cognitive Issues? Past Research Says 'Yes', With Implications For Covid-19 - Forbesforbes.com - July 21 at 5:41 PMHigh-flying experiment: Do stem cells grow better in space? - ABC Newsabcnews.go.com - July 17 at 12:54 PMjCyte Announces Appointment of Dr. Stewart Craig as Chief Technology Officer - StreetInsider.comstreetinsider.com - July 12 at 10:49 PMResearch On Flies Provides Hope For Brain Repair - Forbesforbes.com - July 11 at 6:30 PMStem Cell Assays Market Report 2022-2027: Government Initiatives to Boost Stem Cell Research Present Opportunities - Yahoo Financefinance.yahoo.com - July 7 at 9:20 PMThe Albany College of Pharmacy's plans at the Center for Medical Science building - Albany Business Review - The Business Journalsbizjournals.com - July 7 at 9:20 PMGlobal Stem Cell Assays Market Projected to Reach $4.5 Billion by 2027 - Yahoo Finance UKuk.finance.yahoo.com - July 6 at 6:42 PMGlobal Stem Cell Assays Market Projected to Reach $4.5 Billion by 2027 - GlobeNewswireglobenewswire.com - July 6 at 7:31 AMStem Cell Assays Market Report 2022-2027: Increasing Awareness About Therapeutic Potency of Stem Cells Driving Growth - ResearchAndMarkets.com - Business Wirebusinesswire.com - July 5 at 9:23 AMStem Cell Assays Market worth $4.5 billion by 2027 – Exclusive Report by MarketsandMarkets™ - Yahoo Financefinance.yahoo.com - July 5 at 4:22 AMAlbany College of Pharmacy and Health Sciences buys Center For Medical Science building - Albany Business Review - The Business Journalsbizjournals.com - June 30 at 9:26 PMBOLDEN THERAPEUTICS RECEIVES $497,500 SBIR GRANT FROM THE NATIONAL INSTITUTE ON AGING TO SUPPORT DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDES TO PROMOTE NEUROGENESIS - PR Newswireprnewswire.com - June 29 at 3:21 PMStem Cell Assays Market worth $4.5 billion by 2027 - Exclusive Report by MarketsandMarkets™ - Yahoo Financefinance.yahoo.com - June 21 at 1:20 PMARUNA BIO ANNOUNCES ISSUANCE OF A NEW COMPOSITION OF MATTER PATENT COVERING NEURAL EXOSOMES IN JAPAN - PR Newswireprnewswire.com - June 13 at 9:56 AMChung-Ang University Researchers Use Biomolecule-Loaded Metal-Organic Frameworks Nanopatterns to Aid Artificial Stem Cell Differentiation - PR Newswireprnewswire.com - June 10 at 3:59 PMUTSA awards $4 million to Oskar Fischer Prize recipients for innovative explanations of Alzheimer's disease - Yahoo Financefinance.yahoo.com - June 8 at 10:19 AMAruna Bio Advances Therapeutic Development for Traumatic Brain Injury - PR Newswireprnewswire.com - May 31 at 9:30 PMLUXA BIO Announces First Participant Dosed in Phase 1/2a Clinical Trial of Adult RPESC-RPE-4W for Dry Age-related Macular Degeneration - Business Wirebusinesswire.com - May 24 at 11:43 AMINTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.commarketscreener.com - May 13 at 6:48 PMUnited States to Lead Global Induced Pluripotent Stem Cell (iPSC) Market Growth: Fact.MR Analysis - GlobeNewswireglobenewswire.com - May 5 at 3:45 PMGenenta Science (GNTA) Announces Nomination of Mark A. Sirgo as Chair - StreetInsider.comstreetinsider.com - April 28 at 8:32 PMARUNA BIO APPOINTS STEPHEN FROM AS CHIEF EXECUTIVE OFFICER - PR Newswireprnewswire.com - April 27 at 6:48 PMGenenta Announces Nomination of Mark A. Sirgo as Chair - Yahoo Finance UKuk.finance.yahoo.com - April 27 at 1:48 PM2022 Lurie Prize in Biomedical Sciences Winners Provide Powerful Contributions to Our Understanding of the Aging Process - PR Newswireprnewswire.com - April 14 at 10:11 AMINTERNATIONAL STEM CELL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.commarketscreener.com - March 29 at 5:37 PMAgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results - Yahoo Financefinance.yahoo.com - March 29 at 5:37 PMNOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Changes in Control or Registra - Marketscreener.commarketscreener.com - March 14 at 4:53 PMKringle Pharma : Files Patent Application for Treatment of Chronic Spinal Cord Injury - Marketscreener.commarketscreener.com - March 11 at 4:56 AMCalidi Biotherapeutics and Edoc Acquisition Corp. Agree to Merge and Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies - Yahoo Financefinance.yahoo.com - February 3 at 2:23 AMHow ‘Dormant’ Cells In The Aging Brain Contribute To Cognitive Decline - Forbesforbes.com - February 1 at 2:51 AM Get Neuralstem News Delivered to You Automatically Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter. Email Address The Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you. 4 simple steps to protect your privacy and money before it’s too late. CUR Media Mentions By Week CUR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CUR News Sentiment▼0.000.32▲Average Medical News Sentiment CUR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CUR Articles This Week▼00▲CUR Articles Average Week Get Neuralstem News Delivered to You Automatically Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: COEP News SNTI News IKT News BCDA News ONVO News GENE News SRNE News TTNP News CELZ News APTO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CUR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuralstem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.